Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tdoniger
    Member
    • Nov 2010
    • 13

    #1

    Finishing a de novo assembly of bacteria genome from single-end reads

    I have assembled a ~5Mb bacterial genome using both Edena and CLC Bio. I have about several hundred contigs.

    The lab is willing to sequence to close up some of the gaps - about 50...but not 500. This is a 50 bps reads single-end illumina sequencing (about 200X) DNA-Seq library.

    What is the best approach to try and close some of the gaps?

    Are there specific tools to automate this?

    Can the singleton sequences be helpful?

    There is a genome of a cousin strain that has been sequenced (90-95% similar). Using Mummer, I am able to map the contigs to them, but they have found experimentally that there that there are differences between the strains and I'm not sure where to stick in the contigs that are different.
    Also, how do I handle repetitive sequences. There are some contigs that have much higher coverage than the others > 2000X.

    Again....are there tools or pipelines that can help reduce the number of contigs by merging some together? Any tips on how to proceed?


    Thanks so much,
    Tirza
    --
    Tirza Doniger, Ph.D.
    Bioinformatics Unit
    The Mina and Everard Faculty of Life Sciences
    Bar Ilan University
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    There are lots of threads on this topic on seqanswers. Also try the de novo forum here, there will be a lot of useful information there.

    Generally, you'll struggle to scaffold contigs from single end data. I would advise also trying Velvet for assembly though.

    Comment

    • maubp
      Peter (Biopython etc)
      • Jul 2009
      • 1544

      #3
      Designing PCR primers and capillary sequencing to close gaps is quite expensive (time and money). Assuming you still have DNA for the exact same sample, getting more high throughout sequencing might actually be the most cost effective plan - probably you should get paired end data next time.

      In terms of tools, I've not tried it yet but CONTIGuator seems to do what you need:
      A bacterial genomes finishing tool for structural insights on draft genomes

      Comment

      • sagarutturkar
        Member
        • Sep 2010
        • 61

        #4
        Originally posted by maubp View Post

        In terms of tools, I've not tried it yet but CONTIGuator seems to do what you need:
        [url]http://contiguator.sourceforge.net/[/url

        I have a assembly with 18 scaffolds and a reference genome which have average nucleotide identity of 85% with my genome. I used contiguator and it determined the order of my scaffolds. 11 out of 18 scaffolds alligned to reference genome.

        However, I am not sure how exactly results are calculated or ordering is done. How to interpret the reliability of this order.

        Since my genome is only 85% identical to reference, it might be possible that unmapped scaffolds are part of my genome but not present in reference. How to determine the placement of those scaffolds. Any experience? Any ideas?

        Thanks

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          Yesterday, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        71 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...